I, A., G, P., L, B., C, C., D, V., M, L., . . . F, d. M. (2026). Actionable Gene Alterations in Resected Non-Small Cell Lung Cancer: Primary Results From the AGA-R Study. Clinical lung cancer, 27(2), 259. https://doi.org/10.1016/j.cllc.2025.09.015
Chicago Style (17th ed.) CitationI, Attili, et al. "Actionable Gene Alterations in Resected Non-Small Cell Lung Cancer: Primary Results From the AGA-R Study." Clinical Lung Cancer 27, no. 2 (2026): 259. https://doi.org/10.1016/j.cllc.2025.09.015.
MLA (9th ed.) CitationI, Attili, et al. "Actionable Gene Alterations in Resected Non-Small Cell Lung Cancer: Primary Results From the AGA-R Study." Clinical Lung Cancer, vol. 27, no. 2, 2026, p. 259, https://doi.org/10.1016/j.cllc.2025.09.015.
Warning: These citations may not always be 100% accurate.